Yaz & Yasmin Increase Risk of Blood Clots, Heart Attacks, Strokes, Pulmonary Embolism, & Deep Vein Thrombosis
Yasmin and Yaz are two types of oral conctraceptives manufactured by Bayer Healthcare. Yasmin and Yaz contain the same estrogenic compound, ethinyl estradiol, that has been used since the 1970s, but the progestin in Yasmin and Yaz is new. Yasmin and Yaz both contain drospirenone, a “fourth generation” progestin – no other birth control pills contain drospirenone, except for a recently approved generic version, Ocella, marketed and distributed by Barr Laboratories, Inc.
A study published by the British Medical Journal demonstrated that birth control products containing drospirenone the active ingredient contained in Yaz, Yasmin, a risk of blood clots nearly double that of other birth control medications. Other reports have associated drospirenone with an increased risk of gall bladder disease, resulting in removal.
Drospirenone may act as a diuretic, causing dehydration and increased potassium levels in the blood. The FDA has warned that “increased serum potassium can be dangerous.” Since potassium acts as a key control in cardiac rhythm, this imbalance can disrupt normal heart rhythm and result in the formation of blood clots, stroke, heart attack, deep vein thrombosis (DVT), pulmonary embolism, and even death. Dehydration can also cause kidney stones and gallbladder disease.
From the first quarter of 2004 through the third quarter of 2008, well over 50 reports of death among users of Yasmin and Yaz were filed with FDA. These include numerous deaths with reported cardiac arrhythmia, cardiac arrest, intracardiac thrombus (blood clots in the heart), pulmonary embolism (blood clot in the lungs), and stroke in women under 50 years of age. Some of the deaths were women as young as 17 years old.
On November 6 2009, a recall was instituted for Yaz and Ocella (drospirenone and ethinyl estradiol tablets). Specifically, 155,064 3 blister packages were recalled because of deviating amounts of the active ingredients.
Yaz,Yasmin and other drospirenone containing oral contraceptives have been associated with:
• Blood Clots
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Cerebrovascular Accidents (CVA)
• Heart Attack (Myocardial Infarction)
• Gallbladder Disease/Injury (cholecystitis)
• Gallbladder Removal (cholecystectomy)
The Plymale Law Firm is handling litigation related to these injuries nationwide.
If you or a loved one suffered from blood clots, stroke, heart attack, deep vein thrombosis (DVT), pulmonary embolism, gallbladder disease or removal, or death while using Yaz or Yasmin contact the Plymale Law Firm for a free consultation by filling out the form on this page or by calling (877) 328-7670.